APO Research
Talk to an analyst

APO RESEARCH · REPORT

ALK Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global ALK Inhibitors Industry Growth and Trends Forecast to 2032

31 December 202593 pages

Choose your research edition.

Industry ResearchALK Inhibitors Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal ALK Inhibitors Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal ALK Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ALK Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal ALK Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global ALK Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of ALK Inhibitors include Takeda Pharmaceuticals, Wanbang Biopharmaceuticals, Qilu Pharmaceutical, Novartis, Roche, Jiangsu Aosaikang Pharmaceutical, Pfizer, Betta Pharmaceuticals and Natco Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global ALK Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The ALK Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global ALK Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to ALK Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global ALK Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

ALK Inhibitors Market by Company

Takeda Pharmaceuticals

Wanbang Biopharmaceuticals

Qilu Pharmaceutical

Novartis

Roche

Jiangsu Aosaikang Pharmaceutical

Pfizer

Betta Pharmaceuticals

Natco Pharma

ALK Inhibitors Segment by Type

Alectinib

Brigatinib

Ensartinib

Crizotinib

Lorlatinib

Ceritinib

Iruplinalkib

Other

ALK Inhibitors Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

ALK Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ALK Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ALK Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ALK Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ALK Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of ALK Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alectinib Table 2. Major Company of Brigatinib Table 3. Major Company of Ensartinib Table 4. Major Company of Crizotinib Table 5. Major Company of Lorlatinib Table 6. Major Company of Ceritinib Table 7. Major Company of Iruplinalkib Table 8. Major Company of Other Table 9. Global ALK Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 11. Global ALK Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 12. Global ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 13. Global ALK Inhibitors Sales Market Share in Value by Type (2021-2026) Table 14. Global ALK Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 15. Global ALK Inhibitors Sales by Type (2027-2032) & (K Units) Table 16. Global ALK Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 17. Global ALK Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 18. Global ALK Inhibitors Sales Market Share in Value by Type (2027-2032) Table 19. Global ALK Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 20. North America ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. North America ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Europe ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Europe ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 25. Asia-Pacific ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 27. Latin America ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 29. Middle East and Africa ALK Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 30. ALK Inhibitors Industry Trends Table 31. ALK Inhibitors Industry Drivers Table 32. ALK Inhibitors Industry Opportunities and Challenges Table 33. ALK Inhibitors Industry Restraints Table 34. Global ALK Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global ALK Inhibitors Revenue Market Share by Company (2021-2026) Table 36. Global ALK Inhibitors Sales by Company (2021-2026) & (K Units) Table 37. Global ALK Inhibitors Sales Share by Company (2021-2026) Table 38. Global ALK Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 39. Global ALK Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global ALK Inhibitors Major Company Production Sites and Headquarters Table 41. Global ALK Inhibitors Company, Product Type & Application Table 42. Global ALK Inhibitors Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global ALK Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global ALK Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global ALK Inhibitors Sales by Region (2021-2026) & (K Units) Table 47. Global ALK Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 48. Global ALK Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 49. Global ALK Inhibitors Sales Market Share in Value by Region (2021-2026) Table 50. Global ALK Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Global ALK Inhibitors Sales by Region (2027-2032) & (K Units) Table 52. Global ALK Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 53. Global ALK Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 54. Global ALK Inhibitors Sales Market Share in Value by Region (2027-2032) Table 55. Global ALK Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 56. Global ALK Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 58. Global ALK Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 59. Global ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 60. Global ALK Inhibitors Sales Market Share in Value by Application (2021-2026) Table 61. Global ALK Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 62. Global ALK Inhibitors Sales by Application (2027-2032) & (K Units) Table 63. Global ALK Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 64. Global ALK Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 65. Global ALK Inhibitors Sales Market Share in Value by Application (2027-2032) Table 66. Global ALK Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 67. North America ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. North America ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Europe ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Europe ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 72. Asia-Pacific ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 74. Latin America ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 76. Middle East and Africa ALK Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 77. Takeda Pharmaceuticals Company Information Table 78. Takeda Pharmaceuticals Business Overview Table 79. Takeda Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Takeda Pharmaceuticals ALK Inhibitors Product Portfolio Table 81. Takeda Pharmaceuticals Recent Development Table 82. Wanbang Biopharmaceuticals Company Information Table 83. Wanbang Biopharmaceuticals Business Overview Table 84. Wanbang Biopharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio Table 86. Wanbang Biopharmaceuticals Recent Development Table 87. Qilu Pharmaceutical Company Information Table 88. Qilu Pharmaceutical Business Overview Table 89. Qilu Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Qilu Pharmaceutical ALK Inhibitors Product Portfolio Table 91. Qilu Pharmaceutical Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis ALK Inhibitors Product Portfolio Table 96. Novartis Recent Development Table 97. Roche Company Information Table 98. Roche Business Overview Table 99. Roche ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Roche ALK Inhibitors Product Portfolio Table 101. Roche Recent Development Table 102. Jiangsu Aosaikang Pharmaceutical Company Information Table 103. Jiangsu Aosaikang Pharmaceutical Business Overview Table 104. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio Table 106. Jiangsu Aosaikang Pharmaceutical Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer ALK Inhibitors Product Portfolio Table 111. Pfizer Recent Development Table 112. Betta Pharmaceuticals Company Information Table 113. Betta Pharmaceuticals Business Overview Table 114. Betta Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Betta Pharmaceuticals ALK Inhibitors Product Portfolio Table 116. Betta Pharmaceuticals Recent Development Table 117. Natco Pharma Company Information Table 118. Natco Pharma Business Overview Table 119. Natco Pharma ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Natco Pharma ALK Inhibitors Product Portfolio Table 121. Natco Pharma Recent Development Table 122. North America ALK Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 124. North America ALK Inhibitors Sales Market Share by Country (2021-2026) Table 125. North America ALK Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America ALK Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 127. North America ALK Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America ALK Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 129. North America ALK Inhibitors Market Share by Country (2021-2026) Table 130. North America ALK Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America ALK Inhibitors Market Share Forecast by Country (2027-2032) Table 132. Europe ALK Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 134. Europe ALK Inhibitors Sales Market Share by Country (2021-2026) Table 135. Europe ALK Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe ALK Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 137. Europe ALK Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe ALK Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe ALK Inhibitors Market Share by Country (2021-2026) Table 140. Europe ALK Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe ALK Inhibitors Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific ALK Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific ALK Inhibitors Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific ALK Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific ALK Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific ALK Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific ALK Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific ALK Inhibitors Market Share by Country (2021-2026) Table 150. Asia-Pacific ALK Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific ALK Inhibitors Market Share Forecast by Country (2027-2032) Table 152. Latin America ALK Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 154. Latin America ALK Inhibitors Sales Market Share by Country (2021-2026) Table 155. Latin America ALK Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America ALK Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America ALK Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America ALK Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America ALK Inhibitors Market Share by Country (2021-2026) Table 160. Latin America ALK Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America ALK Inhibitors Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa ALK Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa ALK Inhibitors Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa ALK Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa ALK Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa ALK Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa ALK Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa ALK Inhibitors Market Share by Country (2021-2026) Table 170. Middle East and Africa ALK Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa ALK Inhibitors Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. ALK Inhibitors Distributors List Table 175. ALK Inhibitors Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. ALK Inhibitors Image Figure 2. Global ALK Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ALK Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global ALK Inhibitors Sales (2021-2032) & (K Units) Figure 5. Alectinib Image Figure 6. Global Alectinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Brigatinib Image Figure 8. Global Brigatinib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Ensartinib Image Figure 10. Global Ensartinib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Crizotinib Image Figure 12. Global Crizotinib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Lorlatinib Image Figure 14. Global Lorlatinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Ceritinib Image Figure 16. Global Ceritinib Sales YoY Growth (2021-2032) & (K Units) Figure 17. Iruplinalkib Image Figure 18. Global Iruplinalkib Sales YoY Growth (2021-2032) & (K Units) Figure 19. Other Image Figure 20. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 21. Global ALK Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global ALK Inhibitors Market Share by Type 2025 VS 2032 Figure 23. North America ALK Inhibitors Sales Market Share in Volume by Type in 2025 Figure 24. North America ALK Inhibitors Sales Market Share in Value by Type in 2025 Figure 25. Europe ALK Inhibitors Sales Market Share in Volume by Type in 2025 Figure 26. Europe ALK Inhibitors Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific ALK Inhibitors Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific ALK Inhibitors Sales Market Share in Value by Type in 2025 Figure 29. Latin America ALK Inhibitors Sales Market Share in Volume by Type in 2025 Figure 30. Latin America ALK Inhibitors Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa ALK Inhibitors Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa ALK Inhibitors Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 ALK Inhibitors Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Hospital and Clinic Image Figure 36. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. Retail Pharmacies Image Figure 38. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global ALK Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global ALK Inhibitors Market Share by Application 2025 VS 2032 Figure 43. North America ALK Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. North America ALK Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. Europe ALK Inhibitors Sales Market Share in Volume by Application in 2025 Figure 46. Europe ALK Inhibitors Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific ALK Inhibitors Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific ALK Inhibitors Sales Market Share in Value by Application in 2025 Figure 49. Latin America ALK Inhibitors Sales Market Share in Volume by Application in 2025 Figure 50. Latin America ALK Inhibitors Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa ALK Inhibitors Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa ALK Inhibitors Sales Market Share in Value by Application in 2025 Figure 53. North America ALK Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America ALK Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America ALK Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America ALK Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe ALK Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe ALK Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe ALK Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe ALK Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific ALK Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific ALK Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific ALK Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific ALK Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America ALK Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America ALK Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America ALK Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America ALK Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa ALK Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa ALK Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa ALK Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa ALK Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. ALK Inhibitors Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. ALK Inhibitors Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Alectinib
  • Brigatinib
  • Ensartinib
  • Crizotinib
  • Lorlatinib
  • Ceritinib
  • Iruplinalkib
  • Other
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Takeda Pharmaceuticals
  • Wanbang Biopharmaceuticals
  • Qilu Pharmaceutical
  • Novartis
  • Roche
  • Jiangsu Aosaikang Pharmaceutical
  • Pfizer
  • Betta Pharmaceuticals
  • Natco Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global ALK Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global ALK Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 ALK Inhibitors Market by Type
  6. 1.3.1 Alectinib
  7. 1.3.2 Brigatinib
  8. 1.3.3 Ensartinib
  9. 1.3.4 Crizotinib
  10. 1.3.5 Lorlatinib
  11. 1.3.6 Ceritinib
  12. 1.3.7 Iruplinalkib
  13. 1.3.8 Other
  14. 1.4 Global ALK Inhibitors Market Size by Type
  15. 1.4.1 Global ALK Inhibitors Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global ALK Inhibitors Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global ALK Inhibitors Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America ALK Inhibitors Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe ALK Inhibitors Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific ALK Inhibitors Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America ALK Inhibitors Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa ALK Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 ALK Inhibitors Industry Trends
  2. 2.2 ALK Inhibitors Industry Drivers
  3. 2.3 ALK Inhibitors Industry Opportunities and Challenges
  4. 2.4 ALK Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by ALK Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by ALK Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by ALK Inhibitors Price (2021-2026)
  4. 3.4 Global ALK Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global ALK Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global ALK Inhibitors Company, Product Type & Application
  7. 3.7 Global ALK Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global ALK Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 ALK Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 ALK Inhibitors Tier 1, Tier 2, and Tier 3
4 ALK Inhibitors Regional Status and Outlook
  1. 4.1 Global ALK Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global ALK Inhibitors Historic Market Size by Region
  3. 4.2.1 Global ALK Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global ALK Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global ALK Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global ALK Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global ALK Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global ALK Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global ALK Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 ALK Inhibitors by Application
  1. 5.1 ALK Inhibitors Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global ALK Inhibitors Market Size by Application
  6. 5.2.1 Global ALK Inhibitors Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global ALK Inhibitors Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global ALK Inhibitors Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America ALK Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe ALK Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific ALK Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America ALK Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa ALK Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals
  2. 6.1.1 Takeda Pharmaceuticals Company Information
  3. 6.1.2 Takeda Pharmaceuticals Business Overview
  4. 6.1.3 Takeda Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals ALK Inhibitors Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Recent Developments
  7. 6.2 Wanbang Biopharmaceuticals
  8. 6.2.1 Wanbang Biopharmaceuticals Company Information
  9. 6.2.2 Wanbang Biopharmaceuticals Business Overview
  10. 6.2.3 Wanbang Biopharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio
  12. 6.2.5 Wanbang Biopharmaceuticals Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical ALK Inhibitors Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis ALK Inhibitors Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche ALK Inhibitors Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Jiangsu Aosaikang Pharmaceutical
  32. 6.6.1 Jiangsu Aosaikang Pharmaceutical Company Information
  33. 6.6.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  34. 6.6.3 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio
  36. 6.6.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer ALK Inhibitors Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Betta Pharmaceuticals
  44. 6.8.1 Betta Pharmaceuticals Company Information
  45. 6.8.2 Betta Pharmaceuticals Business Overview
  46. 6.8.3 Betta Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Betta Pharmaceuticals ALK Inhibitors Product Portfolio
  48. 6.8.5 Betta Pharmaceuticals Recent Developments
  49. 6.9 Natco Pharma
  50. 6.9.1 Natco Pharma Company Information
  51. 6.9.2 Natco Pharma Business Overview
  52. 6.9.3 Natco Pharma ALK Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Natco Pharma ALK Inhibitors Product Portfolio
  54. 6.9.5 Natco Pharma Recent Developments
7 North America by Country
  1. 7.1 North America ALK Inhibitors Sales by Country
  2. 7.1.1 North America ALK Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America ALK Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America ALK Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America ALK Inhibitors Market Size by Country
  6. 7.2.1 North America ALK Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America ALK Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America ALK Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe ALK Inhibitors Sales by Country
  2. 8.1.1 Europe ALK Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe ALK Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe ALK Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe ALK Inhibitors Market Size by Country
  6. 8.2.1 Europe ALK Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe ALK Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe ALK Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific ALK Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific ALK Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific ALK Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific ALK Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific ALK Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific ALK Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific ALK Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific ALK Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America ALK Inhibitors Sales by Country
  2. 10.1.1 South America ALK Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America ALK Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America ALK Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America ALK Inhibitors Market Size by Country
  6. 10.2.1 South America ALK Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America ALK Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America ALK Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa ALK Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa ALK Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa ALK Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa ALK Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa ALK Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa ALK Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa ALK Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa ALK Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 ALK Inhibitors Value Chain Analysis
  2. 12.1.1 ALK Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 ALK Inhibitors Production Mode & Process
  7. 12.2 ALK Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 ALK Inhibitors Distributors
  10. 12.2.3 ALK Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst